| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Arrowhead Pharmaceuticals, Inc. (ARWR) has 11 insiders with recent SEC Form 4 filings, including 0 buys and 37 sells. ARWR is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 3.79M | $295.64M | - | |
| COO | 472.8K | $36.86M | - | |
| Other | 227.0K | $17.69M | -10,000 | |
| CFO | 171.6K | $13.38M | -13,095 | |
| Dir | 123.1K | $9.59M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 23, 2026 | Hamilton James C73 | Chief Medical Officer | Sell | 10,000 | $75.00 | $750,000.00 | -4.2% | - | - | |
| Apr 22, 2026 | Apel Daniel Joseph | Chief Financial Officer | Sell | 13,095 | $71.35 | $934,285.13 | -2.5% | - | - | |
| Mar 5, 2026 | Hamilton James C73 | Chief Medical Officer | Sell | 10,000 | $64.19 | $641,900.00 | -4.0% | - | - | |
| Jan 5, 2026 | Hamilton James C73 | Chief Medical Officer | Sell | 40,164 | $63.11 | $2,534,661.46 | -3.0% | -4.3% | - | |
| Jan 5, 2026 | O'Brien Patrick76 | COO | Sell | 49,493 | $63.11 | $3,123,349.43 | -0.8% | -4.3% | - | |
| Jan 2, 2026 | Anzalone Christopher Richard60 | Chief Executive Officer | Sell | 13,187 | $66.10 | $871,702.77 | -0.2% | -10.0% | - | |
| Dec 29, 2025 | Anzalone Christopher Richard60 | Chief Executive Officer | Sale+OE | 51,726 | $69.13 | $3,575,574.78 | -0.7% | -17.2% | - | |
| Dec 26, 2025 | Ferrari Mauro71 | Director | Sell | 7,530 | $70.00 | $527,100.00 | -9.8% | -13.4% | - | |
| Dec 22, 2025 | Anzalone Christopher Richard60 | Chief Executive Officer | Sell | 26,031 | $68.04 | $1,771,022.38 | -0.1% | -17.9% | - | |
| Dec 19, 2025 | Waddill William D.50 | Director | Sell | 8,367 | $67.65 | $566,038.07 | -4.5% | -16.4% | - |